318 related articles for article (PubMed ID: 30530834)
1. The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.
Andrikopoulos P; Kieswich J; Pacheco S; Nadarajah L; Harwood SM; O'Riordan CE; Thiemermann C; Yaqoob MM
J Am Soc Nephrol; 2019 Jan; 30(1):33-49. PubMed ID: 30530834
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis.
Das R; Kim SJ; Nguyen NT; Kwon HJ; Cha SK; Park KS
Kidney Int; 2019 Oct; 96(4):927-941. PubMed ID: 31377057
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
[TBL] [Abstract][Full Text] [Related]
4. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
6. Delayed Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Inhibition by Trametinib Attenuates Systemic Inflammatory Responses and Multiple Organ Injury in Murine Sepsis.
Smith JA; Mayeux PR; Schnellmann RG
Crit Care Med; 2016 Aug; 44(8):e711-20. PubMed ID: 27031380
[TBL] [Abstract][Full Text] [Related]
7. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
[TBL] [Abstract][Full Text] [Related]
8. BMP1 inhibitor UK383,367 attenuates renal fibrosis and inflammation in CKD.
Bai M; Lei J; Wang S; Ding D; Yu X; Guo Y; Chen S; Du Y; Li D; Zhang Y; Huang S; Jia Z; Zhang A
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1430-F1438. PubMed ID: 31545926
[TBL] [Abstract][Full Text] [Related]
9. Trametinib and dactolisib but not regorafenib exert antiproliferative effects on rat pancreatic stellate cells.
Witteck L; Jaster R
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):642-50. PubMed ID: 26663013
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
[TBL] [Abstract][Full Text] [Related]
11. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.
Wang B; Yang LN; Yang LT; Liang Y; Guo F; Fu P; Ma L
Acta Pharmacol Sin; 2024 Jan; 45(1):150-165. PubMed ID: 37696989
[TBL] [Abstract][Full Text] [Related]
12. Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-β and EMT/Slug signalling.
Annaldas S; Saifi MA; Khurana A; Godugu C
Mol Immunol; 2019 Aug; 112():247-255. PubMed ID: 31202101
[TBL] [Abstract][Full Text] [Related]
13. SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction.
Mustafa M; Wang TN; Chen X; Gao B; Krepinsky JC
Am J Physiol Renal Physiol; 2016 Sep; 311(3):F614-25. PubMed ID: 27385736
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine Kinase-2 Deficiency Ameliorates Kidney Fibrosis by Up-Regulating Smad7 in a Mouse Model of Unilateral Ureteral Obstruction.
Schwalm S; Beyer S; Frey H; Haceni R; Grammatikos G; Thomas D; Geisslinger G; Schaefer L; Huwiler A; Pfeilschifter J
Am J Pathol; 2017 Nov; 187(11):2413-2429. PubMed ID: 28807595
[TBL] [Abstract][Full Text] [Related]
16. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
[TBL] [Abstract][Full Text] [Related]
17. Blocking AURKA with MK-5108 attenuates renal fibrosis in chronic kidney disease.
Jiang M; Bai M; Xu S; Wang T; Lei J; Xu M; Huang S; Jia Z; Zhang A
Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166227. PubMed ID: 34311081
[TBL] [Abstract][Full Text] [Related]
18. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.
Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L
Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914
[TBL] [Abstract][Full Text] [Related]
19. Pomolic Acid Ameliorates Fibroblast Activation and Renal Interstitial Fibrosis through Inhibition of SMAD-STAT Signaling Pathways.
Park JH; Jang KM; An HJ; Kim JY; Gwon MG; Gu H; Park B; Park KK
Molecules; 2018 Sep; 23(9):. PubMed ID: 30177595
[TBL] [Abstract][Full Text] [Related]
20. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
